Aguilar Calvo Laboratory
Patricia Aguilar Calvo D.V.M, Ph.D., is an assistant professor of Neurology. Her lab studies the factors that modulate the interaction of misfolded proteins with glycoproteins and the impact in the pathogenesis of prion and Parkinson's diseases.
Arrant Laboratory
Andrew Arrant, Ph.D., is an Assistant Professor of Neurology. His laboratory is focused on the cellular mechanisms underlying Alzheimer's disease and frontotemporal dementia.
Cowell Laboratory
Rita Cowell, Ph.D., is a Professor of Neurology. Her laboratory is focused on identifying the mechanisms underlying cell death in Parkinson's Disease, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis using mouse models of disease.
De Miranda Laboratory
Briana De Miranda, Ph.D., is an Assistant Professor of Neurology. Her laboratory is focused on the role of environmental toxins in the pathogenesis of Parkinson disease.
Goldberg Laboratory
Gray Laboratory
Harms Laboratory
Ashley Harms, Ph.D., is an Assistant Professor of Neurology. Her laboratory is focused on the role of neuroinflammation in Parkinson disease and related disorders including multiple system atrophy.
Herskowitz Laboratory
King Laboratory
Lazar Laboratory
Limdi Laboratory
Nabors Laboratory
Payami Laboratory
Roberson Laboratory
Standaert Laboratory
Ubogu Laboratory
Volpicelli-Daley Laboratory
Laura Volpicelli-Daley, Ph.D., is an Associate Professor of Neurology. Her laboratory is focused on determining how α-synuclein pathology found in Parkinson's disease and Dementia with Lewy Bodies impacts membrane traffic in neurons, as well as how genes implicated in Parkinson's disease impact α-synuclein pathology.
Walker Laboratory
The Walker lab investigates how deep brain stimulation works using a multimodal approach that integrates electroencephalography, electrocorticography, single unit recordings, neuroimaging, and behavioral assessment in patients with movement disorders. Our goal is to obtain new knowledge about the therapeutic mechanism of DBS and to apply these findings to guide technological innovation, both for established indications and for emerging indications in neurology and psychiatry.
Yacoubian Laboratory
CNET Laboratories
The Center for Neurodegeneration and Experimental Therapeutics (CNET) is devoted to finding therapies for neurodegenerative diseases, including Alzheimer’s disease and related dementias, Parkinson’s disease, Huntington’s disease, and ALS. Its core goal is to promote the discovery of novel treatments for neurodegenerative disorders through basic and translational research, to teach scientists and clinicians about these diseases, and to facilitate the application of these discoveries to clinical care of patients.